PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsCurrax Pharmaceuticals
Currax Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OnzetraSumatriptan2016-01-272024-2036
Migraine disorders
,
Cluster headache
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
SilenorDoxepin2010-03-172027-2030
Atopic dermatitis
,
Pruritus
,
Pain
,
Anxiety disorders
,
Psychotic affective disorders
,
Depressive disorder
TreximetNaproxen, Sumatriptan2008-04-152025-2026
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
,
Gastroesophageal reflux
,
Helicobacter infections
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Nausea
,
Sleep initiation and maintenance disorders
,
Allergic rhinitis perennial
,
Urticaria
,
Motion sickness
,
Sneezing
,
Anxiety disorders
,
Sinusitis
,
Asthma
,
Stomach ulcer
,
Migraine disorders
,
Cluster headache
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Naproxen
therapeutic equivalency
,
malnutrition
Sumatriptan
epilepsy
,
migraine disorders
Doxepin
ataxia
,
healthy volunteers/patients
Benzocaine
bipolar disorder
Lorcaserin
healthy volunteers/patients
,
breast neoplasms
,
digestive system neoplasms
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
marijuana abuse
,
peripheral nervous system diseases
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
obesity
,
overweight
,
weight loss
,
weight gain
,
body weight
,
diabetes mellitus
,
cardiovascular diseases
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
drug resistant epilepsy
Arm1
heart failure
,
iron-deficiency anemia
,
iron deficiencies
Prudoxin
parkinson disease
,
carcinoma
,
breast neoplasms
,
dermatitis
,
radiodermatitis
,
neoplasms
,
non-small-cell lung carcinoma
,
thyroid neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
sarcoma
,
lymphoma
,
second primary neoplasms
,
small cell lung carcinoma
,
thymoma
,
mesothelioma
,
thymus neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
irritable bowel syndrome
,
syndrome
,
psychophysiologic disorders
,
somatoform disorders
,
stomatitis
,
mucositis
,
dementia
,
schizophrenia
,
anxiety disorders
,
head and neck neoplasms
,
pain
,
urticaria
,
pruritus
,
sleep initiation and maintenance disorders
,
depression
,
atrophy
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
hiv infections
,
ataxia
,
healthy volunteers/patients
,
drug-related side effects and adverse reactions
,
drug interactions
,
bipolar disorder
,
gastrointestinal diseases
,
dyspepsia
,
digestive system diseases
,
nasopharyngeal carcinoma
,
breakthrough pain
Wellbutrin
intellectual disability
,
tardive dyskinesia
,
dyskinesias
,
developmental disabilities
Apd356
healthy volunteers/patients
,
breast neoplasms
,
digestive system neoplasms
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
marijuana abuse
,
peripheral nervous system diseases
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
obesity
,
overweight
,
weight loss
,
weight gain
,
body weight
,
diabetes mellitus
,
cardiovascular diseases
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
drug resistant epilepsy
Arm2
fertilization in vitro
,
rheumatoid arthritis
,
arthritis
,
prostatic hyperplasia
,
hyperplasia
,
contraception
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis seasonal
,
asthma
,
schizophrenia
,
psychotic disorders
,
bipolar disorder
,
allergic rhinitis perennial
,
metabolic syndrome
,
syndrome
,
hyperlipidemias
,
familial combined hyperlipidemia
,
breast neoplasms
,
hypercholesterolemia
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
chronic urticaria
,
urticaria
,
cardiovascular diseases
,
heart diseases
,
atherosclerosis
,
psoriasis
,
systemic lupus erythematosus
Belviq
healthy volunteers/patients
,
breast neoplasms
,
digestive system neoplasms
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
marijuana abuse
,
peripheral nervous system diseases
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
obesity
,
overweight
,
weight loss
,
weight gain
,
body weight
,
diabetes mellitus
,
cardiovascular diseases
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
drug resistant epilepsy
Mydfrin
thrombosis
,
lung diseases
,
pain
,
biological availability
,
healthy volunteers/patients
,
allergic rhinitis
,
rhinitis
,
erectile dysfunction
,
overactive urinary bladder
,
cognitive dysfunction
,
chronic obstructive pulmonary disease
,
crush injuries
,
sleep initiation and maintenance disorders
,
common cold
,
asthma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use